معرفی
Heather Lazowski is a Researcher at the Yale School of Medicine, Yale University. Her research focuses on lung cancer mechanisms, molecular oncology, and cancer survivorship. She holds a BS in Medical Biology from the University of New England (2008). Key collaborators include Lynn Tanoue, Roy Herbst, and David Rimm. Her work spans genomic mutations (APOBEC, NFE2L2), RAS signaling pathways, and quality-of-life outcomes in lung cancer patients.
Publications include studies in Lung Cancer and Clinical Cancer Research, addressing topics like APOBEC-driven carcinogenesis and therapeutic targets for RAS fusion proteins. Notable contributions include identifying prognostic biomarkers in early-stage lung adenocarcinomas and uncovering MEK inhibition sensitivity in oncogenic RAS-driven tumors.
